MXPA05014127A - Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras. - Google Patents
Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras.Info
- Publication number
- MXPA05014127A MXPA05014127A MXPA05014127A MXPA05014127A MXPA05014127A MX PA05014127 A MXPA05014127 A MX PA05014127A MX PA05014127 A MXPA05014127 A MX PA05014127A MX PA05014127 A MXPA05014127 A MX PA05014127A MX PA05014127 A MXPA05014127 A MX PA05014127A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- pharmaceutical compositions
- bicyclo
- heptane derivatives
- stands
- Prior art date
Links
- 230000000324 neuroprotective effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical class C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Abstract
La invencion se relaciona con el uso de compuestos de la formula general (?), donde R3 significa hidrogeno o hidroxi; R1 significa hidrogeno o alquilo; y R2 significa alquilo) y sales de adicion de acido farmaceuticamente aceptables para la preparacion de composiciones farmaceuticas que tienen efecto neuroprotector. (Ver formula (I)).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0301906A HUP0301906A3 (en) | 2003-06-23 | 2003-06-23 | Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity |
| PCT/HU2004/000062 WO2004112769A1 (en) | 2003-06-23 | 2004-06-22 | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05014127A true MXPA05014127A (es) | 2006-02-24 |
Family
ID=90001689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05014127A MXPA05014127A (es) | 2003-06-23 | 2004-06-22 | Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20060258750A1 (es) |
| EP (1) | EP1660063A1 (es) |
| JP (1) | JP2007516165A (es) |
| KR (1) | KR20060023997A (es) |
| CN (1) | CN1812778A (es) |
| AU (1) | AU2004248982A1 (es) |
| BG (1) | BG109414A (es) |
| BR (1) | BRPI0411772A (es) |
| CA (1) | CA2529254A1 (es) |
| CZ (1) | CZ200631A3 (es) |
| EA (1) | EA010868B1 (es) |
| HR (1) | HRP20060023A2 (es) |
| HU (1) | HUP0301906A3 (es) |
| IL (1) | IL172408A0 (es) |
| IS (1) | IS8239A (es) |
| MX (1) | MXPA05014127A (es) |
| NO (1) | NO20060277L (es) |
| PL (1) | PL378630A1 (es) |
| RS (1) | RS20050954A (es) |
| SK (1) | SK50082006A3 (es) |
| UA (1) | UA81052C2 (es) |
| WO (1) | WO2004112769A1 (es) |
| ZA (1) | ZA200510138B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
| WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
| EP2216023A4 (en) | 2007-11-15 | 2013-03-13 | Takeda Pharmaceutical | CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF |
| CZ2008602A3 (cs) * | 2008-10-09 | 2009-11-25 | Ústav chemických procesu Akademie ved Ceské republiky | Zpusob a zarízení pro izolaci kyseliny tereftalové |
| US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
| US11478467B2 (en) | 2017-05-04 | 2022-10-25 | Sreenivasarao Vepachedu | Targeted drug rescue with novel compositions, combinations, and methods thereof |
| EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
| US6335371B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Method for inducing cognition enhancement |
| HUP0103017A3 (en) * | 2001-07-18 | 2004-05-28 | Egis Gyogyszergyar Nyilvanosan | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use |
-
2003
- 2003-06-23 HU HU0301906A patent/HUP0301906A3/hu unknown
-
2004
- 2004-06-22 ZA ZA200510138A patent/ZA200510138B/xx unknown
- 2004-06-22 RS YUP-2005/0954A patent/RS20050954A/sr unknown
- 2004-06-22 US US10/562,393 patent/US20060258750A1/en not_active Abandoned
- 2004-06-22 SK SK5008-2006A patent/SK50082006A3/sk not_active Application Discontinuation
- 2004-06-22 MX MXPA05014127A patent/MXPA05014127A/es not_active Application Discontinuation
- 2004-06-22 CA CA002529254A patent/CA2529254A1/en not_active Abandoned
- 2004-06-22 UA UAA200600574A patent/UA81052C2/uk unknown
- 2004-06-22 AU AU2004248982A patent/AU2004248982A1/en not_active Abandoned
- 2004-06-22 KR KR1020057024601A patent/KR20060023997A/ko not_active Application Discontinuation
- 2004-06-22 BR BRPI0411772-7A patent/BRPI0411772A/pt not_active IP Right Cessation
- 2004-06-22 EA EA200600022A patent/EA010868B1/ru not_active IP Right Cessation
- 2004-06-22 WO PCT/HU2004/000062 patent/WO2004112769A1/en active Application Filing
- 2004-06-22 EP EP04743721A patent/EP1660063A1/en not_active Withdrawn
- 2004-06-22 JP JP2006516495A patent/JP2007516165A/ja active Pending
- 2004-06-22 PL PL378630A patent/PL378630A1/pl not_active Application Discontinuation
- 2004-06-22 CN CNA2004800177453A patent/CN1812778A/zh active Pending
-
2005
- 2005-12-06 IL IL172408A patent/IL172408A0/en unknown
-
2006
- 2006-01-16 CZ CZ20060031A patent/CZ200631A3/cs unknown
- 2006-01-17 HR HR20060023A patent/HRP20060023A2/xx not_active Application Discontinuation
- 2006-01-18 IS IS8239A patent/IS8239A/is unknown
- 2006-01-19 NO NO20060277A patent/NO20060277L/no not_active Application Discontinuation
- 2006-01-23 BG BG109414A patent/BG109414A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1660063A1 (en) | 2006-05-31 |
| SK50082006A3 (sk) | 2006-05-04 |
| IL172408A0 (en) | 2006-04-10 |
| HUP0301906A3 (en) | 2006-03-28 |
| PL378630A1 (pl) | 2006-05-15 |
| ZA200510138B (en) | 2007-03-28 |
| UA81052C2 (en) | 2007-11-26 |
| HRP20060023A2 (en) | 2006-05-31 |
| KR20060023997A (ko) | 2006-03-15 |
| CN1812778A (zh) | 2006-08-02 |
| HUP0301906D0 (en) | 2003-08-28 |
| WO2004112769A1 (en) | 2004-12-29 |
| AU2004248982A1 (en) | 2004-12-29 |
| CA2529254A1 (en) | 2004-12-29 |
| EA010868B1 (ru) | 2008-12-30 |
| NO20060277L (no) | 2006-01-19 |
| BRPI0411772A (pt) | 2006-08-08 |
| RS20050954A (en) | 2007-08-03 |
| IS8239A (is) | 2006-01-18 |
| CZ200631A3 (cs) | 2006-05-17 |
| HUP0301906A2 (en) | 2006-02-28 |
| EA200600022A1 (ru) | 2006-08-25 |
| BG109414A (bg) | 2006-11-30 |
| JP2007516165A (ja) | 2007-06-21 |
| US20060258750A1 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007005694A (es) | Nuevos derivados de betulina, preparacion y uso de los mismos. | |
| SI1678166T1 (sl) | Inhibitorji proteinske kinaze | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| AP1739A (en) | Azaindoles | |
| TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| MXPA02012033A (es) | Derivados de 2-aminocarbonil-9h-purina. | |
| GB0114286D0 (en) | Nucleoside Derivatives | |
| MXPA03005464A (es) | Agentes antivirales. | |
| TW200608972A (en) | Aryl-pyridine derivatives | |
| TW200738241A (en) | Pyridazine derivatives | |
| EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
| GB9914486D0 (en) | Medicaments | |
| TW200630364A (en) | 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| UA94606C2 (ru) | Производные тиоксантина, композиция, которая их содержит, и их применение в терапии | |
| UA95223C2 (ru) | Производные пиридопиримидина, их получение, их применение в терапии | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| IL184116A0 (en) | Use of thiazolidinone derivatives as antiangiogenic agents | |
| PL1682528T3 (pl) | Pochodne benzo[b][1,4]dioksepiny | |
| IL159880A0 (en) | Arylsulfonyl derivatives with 5-ht6 receptor affinity | |
| MXPA02009643A (es) | Sintesis acortada de derivados de 3,3-diarilpropilamina. | |
| NO20060277L (no) | Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger | |
| DE60114640D1 (en) | Antithrombosemittel | |
| WO2007080324A3 (fr) | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. | |
| MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |